Real World Evidence: Priority Setting for Action
Real World Evidence: Presentations
Sunday, 2 November 2014
Opening and Opening Remarks
- John Sproule, IHE
- Lisa Marsden, VP of Market Access & Government Relations at AstraZeneca Canada
- Vasanthi Srinivasan, Executive Director, Ontario SPOR DSU
PART I: Fit for purpose: When and where is real-world evidence most useful?
- Speaker: Muhammad Mamdani, Director, Applied Health Research Centre, St. Michael's Hospital
Cy Frank, President and CEO, Alberta Innovates Health Solutions
Greg Zaric, Professor, Ivey Business School
Elaine Campbell, President, AstraZeneca Canada Inc.
PART II: Guiding principles for its use: What questions do we need to consider?
- Speaker: Neil Corner, Director, Innovative Solutions (Real World Evidence Lead) at IMS Brogan
Deborah Marshall, Associate Professor, University of Calgary
Robyn Tamblyn, Director, Canadian Institutes of Health Research – Institute for Health Services and Policy Research
Carole McMahon, Patient representative expert, pan-Canadian Oncology Drug Review Expert Review Committee (pERC)
Directed discussion with first session panelists
PART III: Final Thoughts - data access, linkage and public perception of risk.
Moderated discussion with Invited Panelists
Summary of Discussion
Suzanne McGurn, ADM, Ontario MOHLTC
Closing Remarks – Next Steps